CCR
Os receptores de quimiocinas C-C (CCRs) são um grupo de GPCRs que respondem às quimiocinas, moléculas de sinalização que orientam a migração de células imunológicas para locais de inflamação ou infecção. Os CCRs desempenham papéis cruciais nas respostas imunológicas, inflamação e no desenvolvimento de várias doenças, incluindo distúrbios autoimunes e câncer. A modulação da atividade dos CCRs está sendo explorada como uma estratégia terapêutica para condições como artrite reumatoide, esclerose múltipla e infecção pelo HIV. Na CymitQuimica, oferecemos uma gama de moduladores de CCR de alta qualidade para apoiar sua pesquisa em imunologia, inflamação e desenvolvimento terapêutico.
Produtos da "CCR"
Ordenar por
AZD-5672
CAS:AZD-5672 is an antagonist of CCR5 with an IC50 of 0.32 nM.Fórmula:C32H38F2N2O5S2Pureza:95.58%Cor e Forma:SolidPeso molecular:632.78Ref: TM-T30260
1mg202,00€5mg459,00€10mg643,00€25mg938,00€50mg1.311,00€100mg1.786,00€1mL*10mM (DMSO)560,00€C-021 dihydrochloride
CAS:C-021 dihydrochloride is a potent CCR4 antagonist. It potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM.Fórmula:C27H43Cl2N5O2Pureza:98.51%Cor e Forma:SolidPeso molecular:540.57ZK 756326
CAS:ZK 756326: Selective CCR8 agonist, IC50 1.8 μM (human), 2.6 μM (mouse), no CCR4/5, CXCR3/4 action, 28-fold selectivity vs 26 GPCRs, anti-HIV fusion.Fórmula:C21H28N2O3Pureza:99.43%Cor e Forma:SolidPeso molecular:356.46CCR1 antagonist 6
CAS:CCR1 antagonist 6 is a CCR1 antagonist (IC50: 3 nM).Fórmula:C21H23ClN4O3SPureza:98.40% - 99.26%Cor e Forma:SolidPeso molecular:446.95Maraviroc
CAS:Maraviroc: a CCR5 antagonist blocking HIV-1 entry; IC50s-MIP-1α: 3.3nM, MIP-1β: 7.2nM, RANTES: 5.2nM.Fórmula:C29H41F2N5OPureza:100% - 99.55%Cor e Forma:Brown SolidPeso molecular:513.67Ref: TM-T6016
5mg51,00€10mg95,00€25mg160,00€50mg273,00€100mg492,00€200mg633,00€500mg998,00€1mL*10mM (DMSO)59,00€7,4'-Dihydroxyflavone
CAS:7,4'-Dihydroxyflavone (4',7-Dihydroxyflavone) can induce transcription of nodulation (nod) genes in Rhizobium meliloti.Fórmula:C15H10O4Pureza:99.39% - 99.6%Cor e Forma:SolidPeso molecular:254.24CCR1 antagonist 8
CAS:CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay).Fórmula:C22H18FN5O3SCor e Forma:SolidPeso molecular:451.47J-113863
CAS:J-113863 is also a potent antagonist of the human CCR3 (IC50 of 0.58 nM) , but a weak antagonist of the mouse CCR3 (IC50 of 460 nM).Fórmula:C30H37Cl2IN2O2Pureza:98%Cor e Forma:SolidPeso molecular:655.44Ref: TM-T11699
1mg59,00€2mg87,00€5mg126,00€10mg169,00€25mg304,00€50mg527,00€100mg758,00€1mL*10mM (DMSO)180,00€AZD-4818
CAS:AZD-4818 (CCR1 antagonist) is a chemokine CCR1 antagonist for the treatment of chronic obstructive pulmonary disease.Fórmula:C27H32Cl2N2O7Pureza:99.01%Cor e Forma:SolidPeso molecular:567.46R243
CAS:R243 is CCR8 signaling and chemotaxis inhibitor.Fórmula:C21H27NO4Pureza:97.86%Cor e Forma:SolidPeso molecular:357.44Ref: TM-T24700
1mg43,00€2mg56,00€5mg85,00€10mg124,00€25mg220,00€50mg350,00€100mg522,00€1mL*10mM (DMSO)95,00€YM022
CAS:YM022 is a highly effective and selective gastrin/cholecystokinin (CCK)-B receptor antagonist.Fórmula:C32H28N4O3Pureza:98%Cor e Forma:SolidPeso molecular:516.59CCR1 antagonist 7
CAS:CCR1 antagonist 7 (compound 16r) is an antagonist of chemokine receptor 1 (CCR1) with an IC 50 of 4 nM [1].Fórmula:C21H24ClN5O3SPureza:98%Cor e Forma:SolidPeso molecular:461.96BMS-813160
CAS:BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.Fórmula:C25H40N8O2Pureza:99.66% - 99.78%Cor e Forma:SolidPeso molecular:484.64Ref: TM-T4584
1mg63,00€5mg137,00€10mg187,00€25mg341,00€50mg567,00€100mg810,00€500mg1.644,00€1mL*10mM (DMSO)145,00€Cenicriviroc
CAS:Cenicriviroc (TAK-652), oral CCR2/CCR5 blocker, inhibits HIV-1/HIV-2, with strong anti-infective/anti-inflammatory effects.Fórmula:C41H52N4O4SPureza:97.87%Cor e Forma:SolidPeso molecular:696.94Ref: TM-TQ0297
1mg69,00€5mg149,00€10mg235,00€25mg470,00€50mg610,00€100mg793,00€200mg1.064,00€1mL*10mM (DMSO)221,00€BMS CCR2 22
CAS:BMS CCR2 22 is a potent and selective antagonist of CCR2 with calcium flux IC50 of 18 nM, chemotaxis IC50 of 1 nM, and binding IC50 of 5.1 nM.Fórmula:C28H34F3N5O4SPureza:99.05%Cor e Forma:SolidPeso molecular:593.66Ref: TM-T14688
1mg58,00€5mg116,00€10mg183,00€25mg368,00€50mg562,00€100mg758,00€200mg1.017,00€1mL*10mM (DMSO)156,00€CCR4 antagonist 3-1
CAS:CCR4 antagonist 3-1 is a weak inhibitor of [125I]TARC binding and CEM cell migration, with IC50 values of 1.7 μM and 6.4 μM, respectively.Fórmula:C14H12N2SPureza:99.53%Cor e Forma:SolidPeso molecular:240.32MLN-3897
CAS:MLN-3897 is an oral CCR1 antagonist, Ki 2.3 nM, blocks 125I-MIP-1α binding, and inhibits Akt signaling in MM cells.Fórmula:C30H31ClN2O4Pureza:98.62%Cor e Forma:SolidPeso molecular:519.03IPG7236
CAS:IPG7236, a selective CCR8 antagonist, demonstrates notable tumor suppression in a mouse xenograft model of human breast cancer and is applicable in cancerFórmula:C23H31N3O3SPureza:98%Cor e Forma:SolidPeso molecular:429.58Denikitug
Denikitug is a chimeric antibody of the IgG1κ type that targets CCR8, with its corresponding isotype control being HumanIgG1kappa, Isotype Control.Cor e Forma:Odour LiquidNebokitug
Nebokitug is a humanized IgG1κ antibody targeting CCL24, with HumanIgG1kappa, Isotype Control serving as its corresponding isotype control.Cor e Forma:Odour Liquid
